Clinical Trial Update: POSTERIOR SUB-TENON'S Avastin [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of Avastin (bevacizumab) delivered via posterior sub-Tenon’s injection for diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diffuse Diabetic Macular Edema | Phase 4 | Status: WITHDRAWN